Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
Journal of the American Heart Association · 21.03.2023 · 12 (6)
DOI: 10.1161/jaha.122.026943 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 21.03.2023. Verfasst von Riccardo Liga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Pisa University Hospital and Chair of Cardiology University of Pisa Italy. Hauptthemen laut MEDLINE: Myocardial Ischemia, Heart Failure, Cardiomyopathies, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Myocardial revascularization has been advocated to improve myocardial function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for revascularization in patients with ICM and the role of ischemia and viability detection in guiding treatment. Methods and Results We searched for randomized controlled trials evaluating the prognostic impact of revascularization in ICM and the value of viability imaging for patient management. Out of 1397 publications, 4 randomized controlled trials were included, enrolling 2480 patients. Three trials (HEART [Heart Failure Revascularisation Trial], STICH [Surgical Treatment for Ischemic Heart Failure], and REVIVED [REVascularization for Ischemic VEntricular Dysfunction]‐BCIS2) randomized patients to revascularization or optimal medical therapy. HEART was stopped prematurely without showing any significant difference between treatment strategies. STICH showed a 16% lower mortality with bypass surgery compared with optimal medical therapy at a median follow‐up of 9.8 years. However, neither the presence/extent of left ventricle viability nor ischemia interacted with treatment outcomes. REVIVED‐BCIS2 showed no difference in the primary end point between percutaneous revascularization or optimal medical therapy. PARR‐2 (Positron Emission Tomography and Recovery Following Revascularization) randomized patients to imaging‐guided revascularization versus standard care, with neutral results overall. Information regarding the consistency of patient management with viability testing results was available in ≈65% of patients (n=1623). No difference in survival was revealed according to adherence or no adherence to viability imaging.
Conclusions
In ICM, the largest randomized controlled trial, STICH, suggests that surgical revascularization improves patients' prognosis at long‐term follow‐up, whereas evidence supports no benefit of percutaneous coronary intervention. Data from randomized controlled trials do not support myocardial ischemia or viability testing for treatment guidance. We propose an algorithm for the workup of patients with ICM considering clinical presentation, imaging results, and surgical risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Division, Pisa University Hospital and Chair of Cardiology University of Pisa Italy.
- Nuffield Department of Surgical Sciences Oxford University John Radcliffe Hospital Oxford United Kingdom.
- VA Boston Healthcare System Boston University School of Medicine Boston MA.
- Fondazione VillaSerena per la Ricerca, Città Sant'Angelo Italy.
ORCID-Profile: Riccardo Liga, Raffaele De Caterina
Zitieren
APA
Liga, R., Colli, A., Taggart, D. P., Boden, W. E., & De Caterina, R. (2023). Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How. Journal of the American Heart Association, 12(6). https://doi.org/10.1161/jaha.122.026943
Vancouver
Liga R, Colli A, Taggart DP, Boden WE, De Caterina R. Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How. Journal of the American Heart Association. 2023;12(6). doi:10.1161/jaha.122.026943
BibTeX
@article{Liga2023,
author = {Liga, Riccardo and Colli, Andrea and Taggart, David P and Boden, William E and De Caterina, Raffaele},
title = {Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {6},
doi = {10.1161/jaha.122.026943}
}
EUVIMED